Search

Search Constraints

You searched for: Author/Creator Piermattei, Alessia

Search Results

1. 2022-LBA-746-ESGO Implementation of a comprehensive cancer genome profiling programme into clinical practice: an italian experience in a referral centre for gynecological cancers. (27th October 2022)

2. 2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy. (20th October 2022)

3. 2022-RA-1356-ESGO Epithelial ovarian cancer and brain metastases: survival analysis according to the BRCA status. (20th October 2022)

4. 2022-RA-685-ESGO What is beyond brca mutational status in high grade serous ovarian cancer? The role of hormone receptors expression. (20th October 2022)

5. Cerebellar Metastasis From Ovarian Carcinoma Harboring PIK3CA-Activating Mutation: A "Clear" Explanation for Unexpected "Vertigo". (January 2020)

6. Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis. Issue 15 (26th May 2022)

7. Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery. Issue 4 (31st January 2023)

9. Prognostic role of perineural invasion in vulvar squamous cell carcinoma: A systematic review and meta-analysis. Issue 12 (December 2022)

10. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer. Issue 12 (30th October 2020)